1,2-dipalmitoylphosphatidylcholine has been researched along with isoniazid in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gürsoy, A; Kut, E; Ozkirimli, S | 1 |
Banerjee, R; Chimote, G | 2 |
Pinheiro, M; Pisco, S; Reis, S; Silva, AS | 1 |
4 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and isoniazid
Article | Year |
---|---|
Co-encapsulation of isoniazid and rifampicin in liposomes and characterization of liposomes by derivative spectroscopy.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antibiotics, Antitubercular; Chemistry, Pharmaceutical; Cholesterol; Delayed-Action Preparations; Drug Combinations; Isoniazid; Liposomes; Phosphatidylcholines; Rifampin; Solubility; Spectrophotometry, Ultraviolet | 2004 |
Evaluation of antitubercular drug insertion into preformed dipalmitoylphosphatidylcholine monolayers.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antitubercular Agents; Drug Combinations; Drug Compounding; Ethambutol; Excipients; Isoniazid; Membranes, Artificial; Rifampin; Surface Properties | 2008 |
In vitro evaluation of inhalable isoniazid-loaded surfactant liposomes as an adjunct therapy in pulmonary tuberculosis.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Adsorption; Animals; Antitubercular Agents; Biocompatible Materials; Cell Line; Complement Activation; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Stability; Humans; Isoniazid; Liposomes; Materials Testing; Mice; Microbial Sensitivity Tests; Nebulizers and Vaporizers; Particle Size; Pulmonary Surfactants; Surface Properties; Tuberculosis, Pulmonary | 2010 |
Interactions of isoniazid with membrane models: implications for drug mechanism of action.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antitubercular Agents; Binding Sites; Hydrogen-Ion Concentration; Isoniazid; Lipid Bilayers; Liposomes | 2014 |